Evidence map›Paper›PMID 33009422›Full record

ArticleScientific reports2020

Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy.

Tim R Eijgenraam, Bastiaan J Boukens, Cornelis J Boogerd, E Marloes Schouten, Cees W A van de Kolk, Nienke M Stege, Wouter P Te Rijdt, Edgar T Hoorntje, Paul A van der Zwaag, Eva van Rooij and 6 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Identification of disease-specific pathways and modifiers in phospholamban R14del cardiomyopathy: rationale, design and baseline characteristics of DECIPHER-PLN cohort.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2025
    Article
  3. Hypertrophic cardiomyopathy: insights into pathophysiology and novel therapeutic strategies from clinical studies.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Tim R EijgenraamDepartment of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Bastiaan J BoukensDepartment of Medical Biology, University of Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Cornelis J BoogerdHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center Utrecht, Utrecht, The Netherlands.
E Marloes SchoutenDepartment of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Cees W A van de KolkCentral Animal Facility, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Nienke M StegeDepartment of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Wouter P Te RijdtDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Edgar T HoorntjeDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Paul A van der ZwaagDepartment of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Eva van RooijHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center Utrecht, Utrecht, The Netherlands.
J Peter van TintelenDepartment of Genetics, University of Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands.
Maarten P van den BergDepartment of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Peter van der MeerDepartment of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Jolanda van der VeldenDepartment of Physiology, University of Amsterdam, Amsterdam University Medical Center, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
Herman H W SilljéDepartment of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Rudolf A de BoerDepartment of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. r.a.de.boer@umcg.nl.
University of Groningen · NLUniversity Medical Center Groningen · NLUniversity Medical Center Utrecht · NLAmsterdam University Medical Centers · NLRoyal Netherlands Academy of Arts and Sciences · NLUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID33009422
PMCPMC7532180
OpenAlexW3091154100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.